₹1.50 to ₹85: Multibagger penny stock turns ₹1 lakh into ₹57 lakh in two years
Multibagger penny stock: Making significant profits in the stock market isn't an overnight task—it requires in-depth research and plenty of patience. Investors are always on the lookout for multibagger stocks with the potential to yield exceptional returns. With this in focus, let's take a closer look at the share price journey of one such company: Aayush Wellness.
The multibagger penny stock - Aayush Wellness - which was once priced at ₹ 1.50 in April 2023 - is now currently trading at ₹ 85 on Bombay Stock Exchange.
To put it in perspective, an investment of ₹ 1 lakh made two years ago in the stock and held over time would have grown significantly to nearly ₹ 57 lakh.
Stock has traded ex-bonus and ex-split in 2024. Hence, we have not included the benefit of post-bonus and post-split in this calculation.
The multibagger stock is trading 2 per cent higher at ₹ 85 in Monday's trading session.
Aayush Wellness share price has rewarded its long-term investors with multibagger returns by soaring over 5,261.64 per cent in five years.
However, the penny stock has remained volatile in the short-term. Aayush Wellness share saw a significant surge of 52 per cent in over a month, however, fell 30.41 per cent in terms of year-to-date (YTD).
Aayush Wellness announced stock split in August 2024, where the face value of its shares was changed from ₹ 10 to ₹ 1, in a 1:10 ratio. The ex-split date was August 5, 2024. The company also announced a 1:2 bonus issue in December 2024, giving one bonus share for every two shares held.
Established in 1989, the company provides solutions in health and wellness, dedicated to offering products that merge wellbeing with innovation.
On Monday, the company announced that it has opened its first healthcare centre in Virar (Mumbai), Maharashtra.
Inspired by the E Sanjeevani National Telemedicine Service of the Ministry of Health and Family Welfare, Aayush Wellness has installed a health ATM that shall conduct a wide range of diagnostics tests, in 2-3 minutes, maintain digital health records, and also facilitate Telemedicine to address health deficiencies before they become critical.
The company plans to invest up to ₹ 25 crores in the first phase and shall review further investments based on business requirements. This expansion will increase company's physical presence across geographies all over India, improve the offline distribution network for our products and provide complete preventive healthcare solutions under one roof.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
3 hours ago
- Business Standard
Covid booster jab not needed, say experts; high-risk groups need protection
Public health experts recommend a risk-based Covid response focused on the elderly and immunocompromised instead of mass booster vaccination campaigns Sanket Koul New Delhi Listen to This Article Amid concerns over the rise in Covid-19 cases last month, doctors and public health experts believe that India might benefit from a focused approach on protecting high-risk groups from infection instead of pushing for mass booster dose coverage. This comes even as India reported 6,133 active Covid-19 cases as of 8 June, a tally that stood at just 35 on 28 April, according to data from the Ministry of Health and Family Welfare's Covid dashboard. Commenting on the same, public health expert Dr K Srinath Reddy said that the focus should be on protecting vulnerable population groups such
Time of India
4 hours ago
- Time of India
Explained: How new rule tweak frees up stock brokers to invest beyond securities
Live Events In a welcome step for the broking industry, the government has amended Rule 8 of the Securities Contracts (Regulation) Rules, 1957 ( SCRR ), providing long-awaited clarity on what does not constitute 'business' for a stockbroker. The amendment addresses a long-standing industry concern around regulatory restrictions that limited brokers from investing their own surplus funds in non-securities 8 of the SCRR lays down the eligibility conditions for a person to act as a stockbroker or a member of a recognised stock exchange . Under sub-rules (1)(f) and (3)(f), brokers are prohibited from engaging in any business other than that of securities, unless such business is carried out without any personal financial liability. This essentially prevented brokers from exposing themselves to financial risks unrelated to their core broking time, the National Stock Exchange and the Bombay Stock Exchange issued circulars that significantly widened the interpretation of 'business' under Rule 8 of the SCRR. These circulars clarified that even passive investments in group companies (subsidiary or associate) engaged in non-securities businesses (such as NBFCs, real estate or insurance) would be treated as 'business' and would be in violation of Rule 8. This interpretation created a regulatory overhang that discouraged brokers from investing their own profits outside the securities practice, brokers were restricted from investing their retained earnings or surplus capital into group ventures operating outside the securities domain, even where such investments posed no financial risk to the broker or its clients. This created a significant operational constraint. If a broker wished to invest in a non-securities business, it first had to route profits to its parent, typically via dividends or buybacks, incurring additional tax liabilities before the funds could be redeployed by the parent. This structure was inefficient and deterred brokers from pursuing legitimate investment opportunities that could enhance their business offerings and these industry concerns, the Ministry of Finance released a consultation paper in September 2024 proposing a more nuanced interpretation of Rule 8. It clarified that the original intent of the restriction was to protect client interests and ensure the financial soundness of the brokers, not to place undue limitations on the use of their own capital. Since stockbrokers are already subject to stringent SEBI regulations aimed at safeguarding client funds, further restricting them from investing in group companies engaged in non-securities businesses under the guise of protecting client funds seemed excessive and position has now been codified through an amendment to Rule 8. It now clarifies that a broker's investment activity will not be treated as 'business', unless it involves client funds, client securities or creates a financial obligation for the broker. This empowers brokers to freely invest their retained earnings and surplus capital in group companies or unrelated ventures, so long as client interests remain unaffected. Brokers can now participate in broader financial services ecosystems such as lending or insurance through subsidiaries, allowing them to diversify revenue streams and build integrated financial this amendment to Rule 8 is now effective and offers much-needed regulatory clarity, it is worth noting that the circulars issued by NSE and BSE interpreting the earlier position have not yet been formally withdrawn. This could create some ambiguity for brokers on how the exchanges will align with the amended Rule 8, particularly given that the validity of the NSE circular had been challenged before the Bombay High Court. Until the exchanges formally update their stance, brokers may continue to face uncertainty in practice despite the regulatory intent to liberalise.(The authors Prashanth Ramdas is Partner and Shivaang Maheshwari is Associate at Khaitan & Co. The views expressed are personal.)
Hindustan Times
5 hours ago
- Hindustan Times
India's active Covid-19 cases rise to 6,133, six deaths in last 24 hours
India's active Covid-19 case tally has crossed the 6,000-mark with 378 fresh cases reported in the last 24 hours, Ministry of Health and Family Welfare's (MoHFW) data on Sunday, June 8, showed. India's active Covid-19 case tally stood at 6,133, with Kerala making the biggest contribution in the fresh infections, followed by Gujarat and West Bengal. -Active Covid-19 cases in India: India's active Covid-19 cases rose by 378 since Saturday to stand at 6,133, while 753 people with the infection were cured or discharged in the last 24 hours, the health ministry's data on Sunday showed. -Covid deaths: India also logged six deaths between Saturday and Sunday – two in Karnataka, three in Kerala and one in Tamil Nadu. Details of which are as follows: Karnataka - A 4- year old male with Cor pulmonale, Pulmonary Arterial Hypertension and incidental Covid-19 positive, a 78-year old male with Ischemic Heart Disease, Immune Thrombocytopenic Purpura (and incidental Covid positive. -Kerala Covid deaths: Among the three Covid fatalities in Kerala was a 51-year-old male with SHT, CAD, CKD, a 64-year-old ma;e with T2 DM, CKD, oesophageal adenocarcinoma with metastasis and a 92-year-old male with CAD-Post CABG, CKD Multiple Myeloma, AKI, as per the health ministry. In Tamil Nadu, the patient was a 42-year old male with uncontrolled Diabetes Mellitus, Acute Kidney Disease and seizure disorder. -Kerala, Gujarat log highest cases: Kerala, Gujarat, West Bengal, Rajasthan and Delhi recorded most cases in the last 24 hours. Kerala recorded 144 fresh Covid cases, Gujarat 105, West Bengal 71, Gujarat 24 and Delhi 21. Of the total 6,133 active Covid-19 cases in India, Kerala has the highest share with 1,950 infections. -Cured/discharged: Meanwhile, the number of Covid patients cured or discharged since January 1 this year stood at 6,237 on Sunday. Since January this year, 65 deaths have been reported in the country. There were a total of 257 active patients in the country on May 22.
